Author: Himanshu Patni
12 August 2023
Due to changes in lifestyle and an aging population, the prevalence of diabetes is rapidly rising in nations like India, China, and Japan. In Asia-Pacific, about 227 million people live with type 2 diabetes and about half of them are undiagnosed and unaware of developing long-term complications, in 2020, as per the OECD iLibrary. POC HbA1c testing was adopted as a result of the strong demand for efficient and convenient diagnostic solutions created by the rising prevalence of diabetes. Technological advancements have significantly influenced the adoption of POC HbA1c testing in APAC. Additionally, initiatives and policies to improve diabetes management have been implemented by APAC governments. POC testing plays a crucial role in facilitating timely interventions in these programs, which frequently places an emphasis on early detection and control.
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=42655
Further,the APAC Poc Hba1C Testing Market is expected to grow at a strong CAGR of 11% during the forecast period (2022-2028). The rising technological advancements, increasing investment in healthcare, and supportive government initiatives are all contributing to the significant growth of the POC HbA1c testing market in the APAC region. For instance, in October 2021, ARKRAY’s The Lab 001 uses cutting-edge technology to provide HbA1c results in just 90 seconds. Pioneering diabetes HbA1c POC testing solution launches at DPC2021.
Based on product, the market is segmented into instruments and consumables. Amongst these, the instrument segment held a significant share of the market in 2021. It is anticipated that the development of portable and handheld instruments will make POC HbA1c Testing more accessible, making it possible to conduct the test in a variety of settings. Accordingly, the improvement of cutting-edge instruments for POC HbA1c Testing is supposed to drive the development of the market during the forecast period.
By technology, the market is segmented into wireless ion–exchange HPLC, enzymatic assay, affinity binding chromatography, and turbidimetric inhibition immunoassay. Among these, ion-exchange HPLC (Ion Exchange High-Performance Liquid Chromatography) held a major share of the market in 2021. This technique offers excellent accuracy, reproducibility, and resolution, making it a gold standard for HbA1c measurement in clinical laboratories. The implementation of POC testing has been made even easier by the development of portable and miniaturized ion-exchange HPLC systems. These systems enable prompt interventions and patient counseling by allowing for rapid analysis and immediate results for healthcare professionals.
For a detailed analysis of the Global Poc Hba1C Testing Market browse through –https://univdatos.com/report/poc-hba1c-testing-market/
Global Poc Hba1C Testing Market Segmentation
Market Insight, by Product
· Instruments
· Consumables
Market Insights, by Technology
· ION– Exchange HPCL
· Enzymatic Assay
· Affinity Binding Chromatography
· Turbidimetric Inhibition Immunoassay
Market Insights, by End-Users
· Hospitals
· Clinics
· Ambulatory Surgery Centres
· Others
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
· APAC
o China
o Japan
o India
o Rest of APAC
· Rest of the World
Top Company Profiles
· F. Hoffmann-La Roche Ltd
· BD
· QIAGEN
· Danaher
· Quidel Corporation
· Siemens Healthcare GmbH
· Abbott
· BIOMÉRIEUX
· Nova Biomedical
· NIPRO
Get a call back
